Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Melanoma

  Free Subscription


3 Ann Surg Oncol
1 Anticancer Res
1 Br J Dermatol
1 Cancer Res
2 Clin Cancer Res
3 J Am Acad Dermatol
1 J Clin Oncol
1 J Immunother
2 J Invest Dermatol
4 Melanoma Res
1 N Engl J Med
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

  1. SONG Y, Karakousis GC
    ASO Author Reflections: Survival for Stage III Melanoma-Where Do We Stand in the Current Landscape of Melanoma Therapies?
    Ann Surg Oncol. 2019 Oct 1. pii: 10.1245/s10434-019-07888.
    PubMed     Text format    

  2. THOMAS DC, Han D
    ASO Author Reflections: Recurrence of Melanoma After a Negative Sentinel Node Biopsy-Predictors and Impact of Recurrence Site on Survival.
    Ann Surg Oncol. 2019 Sep 30. pii: 10.1245/s10434-019-07889.
    PubMed     Text format    

  3. ANGELES CV, Wong SL, Karakousis G
    The Landmark Series: Randomized Trials Examining Surgical Margins for Cutaneous Melanoma.
    Ann Surg Oncol. 2019 Sep 27. pii: 10.1245/s10434-019-07866.
    PubMed     Text format     Abstract available

    Anticancer Res

  4. DRACA D, Mijatovic S, Krajnovic T, Kaluderovic GN, et al
    Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle.
    Anticancer Res. 2019;39:5403-5415.
    PubMed     Text format     Abstract available

    Br J Dermatol

  5. CLAESON M, Baade P, Brown S, Soyer HP, et al
    Clinicopathological factors associated with death from thin (</=1.00mm) melanoma.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18560.
    PubMed     Text format     Abstract available

    Cancer Res

  6. BOUKERCHE H, Su ZZ, Emdad L, Baril P, et al
    Editor's Note: mda-9/Syntenin: A Positive Regulator of Melanoma Metastasis.
    Cancer Res. 2019;79:5127.
    PubMed     Text format    

    Clin Cancer Res

  7. NAMIKAWA K, Aung PP, Milton DR, Tetzlaff MT, et al
    Correlation of tumor burden in sentinel lymph nodes with tumor burden in non-sentinel lymph nodes and survival in cutaneous melanoma.
    Clin Cancer Res. 2019 Sep 30. pii: 1078-0432.CCR-19-1194.
    PubMed     Text format     Abstract available

  8. LUKE JJ, Olson DJ, Allred JB, Strand CA, et al
    Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201).
    Clin Cancer Res. 2019 Sep 26. pii: 1078-0432.CCR-19-1223.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  9. KONG L, Tan K, Tan H, Li J, et al
    Utilization of Magnetic Resonance Imaging as a Non-Invasive Imaging Technique To Identify Acral Lentiginous Melanoma.
    J Am Acad Dermatol. 2019 Sep 24. pii: S0190-9622(19)32769.
    PubMed     Text format    

  10. OH Y, Choi S, Cho MY, Nam KA, et al
    Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
    J Am Acad Dermatol. 2019 Sep 25. pii: S0190-9622(19)32773.
    PubMed     Text format     Abstract available

  11. WALDMAN RA, Grant-Kels JM, Curiel CN, Curtis J, et al
    Consensus Recommendations for the Use of Non-Invasive Melanoma Detection Techniques Based on Results of an International DELPHI Process.
    J Am Acad Dermatol. 2019 Sep 26. pii: S0190-9622(19)32794.
    PubMed     Text format    

    J Clin Oncol

  12. MENZER C, Menzies AM, Carlino MS, Reijers I, et al
    Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.
    J Clin Oncol. 2019 Oct 3:JCO1900489. doi: 10.1200/JCO.19.00489.
    PubMed     Text format     Abstract available

    J Immunother

  13. FROHLICH M, Wang H, Sakr L
    Sarcoid-like Reaction Discovered on EBUS-TBNA of Intrathoracic Lymph Nodes During Immunotherapy for Metastatic Melanoma.
    J Immunother. 2019 Sep 24. doi: 10.1097/CJI.0000000000000298.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  14. TORRES R, Lang UE, Hejna M, Shelton SJ, et al
    MicroRNA ratios distinguish melanomas from nevi.
    J Invest Dermatol. 2019 Aug 22. pii: S0022-202X(19)31788.
    PubMed     Text format     Abstract available

  15. GIBBS DC, Orlow I, Vernali S, Powell HB, et al
    Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma.
    J Invest Dermatol. 2019 Sep 27. pii: S0022-202X(19)33239.
    PubMed     Text format    

    Melanoma Res

  16. CHRISTENSEN JN, Schmidt H, Steiniche T, Madsen M, et al
    Identification of robust reference genes for studies of gene expression in FFPE melanoma samples and melanoma cell lines.
    Melanoma Res. 2019 Sep 24. doi: 10.1097/CMR.0000000000000644.
    PubMed     Text format     Abstract available

  17. KOSCHE C, Stout M, Sosman J, Lukas RV, et al
    Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.
    Melanoma Res. 2019 Sep 24. doi: 10.1097/CMR.0000000000000642.
    PubMed     Text format     Abstract available

  18. LI C, Liu T, Tavtigian SV, Boucher K, et al
    Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.
    Melanoma Res. 2019 Sep 24. doi: 10.1097/CMR.0000000000000645.
    PubMed     Text format     Abstract available

  19. DE GIORGI V, Scarfi F, Gori A, Maida P, et al
    Nevi and Breslow thickness in melanoma: sex differences?
    Melanoma Res. 2019 Jan 30. doi: 10.1097/CMR.0000000000000579.
    PubMed     Text format     Abstract available

    N Engl J Med

  20. LARKIN J, Chiarion-Sileni V, Gonzalez R, Grob JJ, et al
    Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1910836.
    PubMed     Text format     Abstract available

    Oncol Rep

  21. LICARETE E, Rauca VF, Luput L, Patras L, et al
    The prednisolone phosphateinduced suppression of the angiogenic function of tumorassociated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
    Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7346.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.